Top 10 Companies in the Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market (2026): Market Leaders Powering Global Industry

MARKET INSIGHTS

Global Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market size was valued at USD 52 million in 2025. The market is projected to grow from USD 55.8 million in 2026 to USD 98.5 million by 2034, exhibiting a CAGR of 7.4% during the forecast period.

Curdlan Beta‑1,3‑Glucan is a unique microbial biopolymer produced by bacteria such as Agrobacterium species. As a linear homopolymer of D‑glucose units linked by β‑1,3‑glycosidic bonds, it stands out for its ability to form resilient, heat‑stable gels upon heating. These properties make it particularly effective as an encapsulant in various applications, providing protective barriers for active ingredients while enabling controlled release.

Global market is experiencing steady expansion driven by growing demand for natural, biodegradable encapsulants across the food, pharmaceutical, and nutraceutical industries. While traditional synthetic polymers have long dominated encapsulation technologies, the shift toward sustainable and biocompatible alternatives has positioned Curdlan favorably. Its film‑forming and gelling capabilities support applications in drug delivery systems, where it helps protect sensitive compounds from degradation and facilitates targeted release profiles. In food processing, it serves as a stabilizer and fat replacer, aligning with consumer preferences for clean‑label products.

Advancements in microbial fermentation techniques have improved production efficiency and cost‑effectiveness, supporting broader adoption. However, challenges remain in scaling output while maintaining consistent quality and purity standards required for high‑value encapsulant uses. Key industry participants continue to invest in research to expand its functionality through modifications, enhancing solubility and compatibility with diverse formulations. Overall, the combination of regulatory support for natural additives and innovation in biopolymer science underpins the positive outlook for this specialized market segment.

Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market – View in Detailed Research Report

Top 10 Companies in the Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market

1️⃣ Seikagaku Corp.

Headquarters: Osaka, Japan
Key Offering: High‑purity Curdlan for food and pharmaceutical applications

Seikagaku Corp. is a leading manufacturer of Curdlan, leveraging proprietary fermentation strains that yield high‑degree polymerization (>1,000). The company supplies both microbial‑derived and enzymatically modified variants, catering to premium drug delivery and clean‑label food markets.

Sustainability Initiatives:

• Optimized nitrogen‑limited fermentation to reduce water usage
• Closed‑loop purification system cutting energy consumption by 15%
• Partnerships with food‑tech startups for biodegradable packaging

2️⃣ Koyo Chemical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Curdlan blends for nutraceutical and cosmetic formulations

Koyo Chemical Co. focuses on specialty grades with enhanced gelation properties, supporting sustained release in oral supplements and texture‑enhancing cosmetic products.

Sustainability Initiatives:

• Renewable energy sourcing for fermentation facilities
• Waste‑heat recovery to power downstream crystallization
• Certification of product safety for food‑grade applications

3️⃣ Hayashibara Co., Ltd.

Headquarters: Nagoya, Japan
Key Offering: High‑performance Curdlan for pharmaceutical encapsulation

Hayashibara specializes in specialty grades with superior gelation, enabling precise control of drug release profiles in oral and injectable formulations.

Sustainability Initiatives:

• Investment in bioreactor scale‑up to reduce per‑kg production cost
• Use of biodegradable packaging materials for finished goods
• Collaboration with academic institutions on functional food R&D

4️⃣ Mitsubishi Chemical

Headquarters: Tokyo, Japan
Key Offering: Hybrid biopolymer blends combining Curdlan with synthetic polymers

Mitsubishi Chemical develops hybrid blends that offer premium texture and stability for high‑value applications such as medical devices and advanced cosmetics.

Sustainability Initiatives:

• Carbon‑neutral production target by 2030
• Life‑cycle assessment of product lines to identify hotspots
• Funding of green chemistry research in collaboration with universities

5️⃣ Dongbang Biotech

Headquarters: Seoul, South Korea
Key Offering: Environmentally focused Curdlan for food and nutraceuticals

Dongbang Biotech has invested in next‑generation fermentation platforms that reduce water usage and improve batch consistency, positioning it as a sustainable alternative in the market.

Sustainability Initiatives:

• Implementation of zero‑liquid‑discharge processes
• Renewable energy integration for fermentation units
• Partnerships with local farmers to source raw materials sustainably

6️⃣ Zhejiang Tianyi Bio‑Technology Co., Ltd.

Headquarters: Zhejiang, China
Key Offering: High‑yield Curdlan for pharmaceutical and food sectors

Zhejiang Tianyi focuses on high‑yield bacterial strains and efficient downstream crystallization, delivering cost‑competitive Curdlan at scale.

Sustainability Initiatives:

• Use of waste‑derived feedstocks for fermentation
• Implementation of green chemistry principles in purification
• Engagement in circular economy initiatives for packaging waste

7️⃣ Shandong Xindian Biotech

Headquarters: Shandong, China
Key Offering: Customized Curdlan functionalization for targeted drug delivery

Shandong Xindian offers functionalized Curdlan derivatives that enable site‑specific release in pharmaceutical formulations.

Sustainability Initiatives:

• Eco‑friendly modification processes with minimal solvent use
• Life‑cycle assessment of functionalized products
• Collaboration with biotech firms to develop next‑generation excipients

8️⃣ Custen Biotech

Headquarters: San Diego, USA
Key Offering: Natural texture enhancer for cosmetics and personal care

Custen Biotech partners with cosmetic brands to incorporate Curdlan as a natural texture enhancer, providing a clean‑label alternative to synthetic thickeners.

Sustainability Initiatives:

• Use of sustainably sourced bacterial strains
• Carbon‑neutral manufacturing facility
• Investment in biodegradable packaging for finished products

9️⃣ Biotech Co. Japan

Headquarters: Kyoto, Japan
Key Offering: Curdlan for functional foods and dietary supplements

Biotech Co. supplies high‑purity Curdlan tailored for probiotic encapsulation and functional food applications, supporting gut‑health products.

Sustainability Initiatives:

• Use of renewable energy for fermentation plants
• Zero‑waste policy in downstream processing
• Partnerships with health‑food retailers for product development

🔟 BioPolymer Ltd.

Headquarters: London, UK
Key Offering: Hybrid Curdlan‑based biopolymers for packaging and food contact applications

BioPolymer Ltd. develops hybrid biopolymers that combine Curdlan with other natural polymers, creating materials suitable for biodegradable packaging and food contact surfaces.

Sustainability Initiatives:

• Carbon‑negative production target by 2035
• Life‑cycle assessment to optimize material usage
• Collaboration with environmental NGOs to promote circular packaging

Download FREE Sample Report: Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market – View in Detailed Research Report

Get Full Report: Curdlan Beta‑1,3‑Glucan Microbial Biopolymer Encapsulant Market – View in Detailed Research Report

Outlook

Global market is projected to grow at a steady CAGR of 7.4% from 2025 to 2034, driven by increasing demand for natural, biodegradable encapsulants in food, pharmaceutical, and nutraceutical sectors. Regulatory support for clean‑label ingredients and ongoing innovation in microbial fermentation are expected to further accelerate market expansion.

Future Trends

• Expansion of Curdlan‑based drug delivery platforms, including hydrogels and controlled‑release formulations for oncology and antiviral therapies.
• Growth of probiotic encapsulation and prebiotic functional foods, leveraging Curdlan’s immunomodulatory properties.
• Adoption of Curdlan in sustainable packaging solutions, replacing synthetic polymers in food contact applications.
• Advancements in enzymatic modification techniques to improve solubility and broaden formulation compatibility.
• Increased collaboration between academia and industry to unlock new high‑value applications in tissue engineering and targeted therapies.